Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Amberg
Clinical trial register · Germany

Clinical Trials in Amberg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest5 Women's Cancer Study Group GmbH2 AbbVie2 Novo Nordisk A/S2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Amberg

48 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
AstraZeneca
Phase 3
600
Amberg, Bad Oeynhausen, Berlin, Bochum, Brandenburg an der Havel, Daaden, Duisburg, Eisenach
2026-07-08
Recruiting
Novo Nordisk A/S
Phase 2
300
Amberg, Bad Oeynhausen, Berlin, Bochum, Bünde, Essen, Hof, Mannheim
2026-06-22
Recruiting
Women's Cancer Study Group GmbH
Phase 3
1,520
Mannheim, Tübingen, Esslingen am Neckar, Freiburg im Breisgau, Amberg, Augsburg, München, Würzburg
2026-04-29
Recruiting
Timo Munz
Observational
543
Amberg, Berlin, Chemnitz, Dresden, Duisburg, Freiburg im Breisgau, Hamburg, Kassel
2026-03-02
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
33
Amberg, Berlin, Düsseldorf, Essen, Frankfurt am Main, Hamburg, Mainz, München
2025-12-16
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
140
Amberg, Bad Saarow, Berlin, Bochum, Düsseldorf, Essen, Frankfurt, Frankfurt am Main
2025-10-27
Recruiting
Novo Nordisk A/S
Phase 4
586
Amberg, Bad Mergentheim, Bad Reichenhall, Berlin, Bünde, Daaden, Dortmund, Dresden
2025-08-15
Recruiting
AstraZeneca
Phase 3
800
Amberg, Chemnitz, Dresden, Essen, Frankfurt am Main, Freiburg im Breisgau, Hamburg, Heidelberg
2025-08-01
Recruiting
AstraZeneca
Phase 3
15,100
Amberg, Bad Bevensen, Bad Friedrichshall, Bad Homburg, Bad Oeynhausen, Bechhofen, Berlin, Bielefeld
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Amberg, Bad Homburg, Berlin, Dresden, Essen, Falkensee, Frankfurt, Freiburg im Breisgau
2025-05-28
Recruiting
AstraZeneca
Observational
150
Amberg, Bad Nauheim, Bautzen, Berlin, Bielefeld, Bonn, Borna, Bottrop
2025-05-20
Recruiting
AstraZeneca
Phase 3
830
Amberg, Augsburg, by, Bad Saarow, Berlin, Bonn, Braunschweig, Essen, Flensburg
2025-04-10
Active, closed
Immutep S.A.S.
Phase 3
756
Amberg, Augsburg, Bad Saarow, Berlin, Cologne, Frankfurt, Frankfurt am Main, Gauting
2025-03-21
Recruiting
AstraZeneca
Phase 3
11,300
Aachen, Amberg, Bad Homburg, Bad Oeynhausen, Bamberg, Bechhofen, Berlin, Bochum
2025-03-14
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
126
Aachen, Amberg, Augsburg, Bad Saarow, Berlin, Bielefeld, Chemnitz, Dortmund
2025-03-03
Recruiting
AbbVie
Observational
1,200
Amberg, Planegg, Hohen Neuendorf, Templin, Frankfurt am Main, Wetzlar, Hanover, Kassel
2025-01-31
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Amberg, Bielefeld, Dresden, Hamburg, Hanover, Heilbronn, Reutlingen
2024-11-22
Recruiting
AbbVie
Observational
678
Freiburg im Breisgau, Heidelberg, Tübingen, Ulm, Amberg, Augsburg, Bamberg, Erlangen
2024-11-07
Recruiting
Hoffmann-La Roche
Observational
842
Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin
2024-09-26
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Amberg, Bamberg, Berlin, Bremen, Chemnitz, Düsseldorf, Frankfurt, Freiburg im Breisgau
2024-06-07
Active, closed
AstraZeneca
Phase 3
2,554
Aachen, Amberg, Bad Oeynhausen, Berlin, Bochum, Dresden, Essen, Falkensee
2024-03-29
Active, closed
Nikolaj Frost MD
Phase 4
136
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2023-12-06
Recruiting
AstraZeneca
Observational
800
Amberg, Ansbach, Apolda, Aschaffenburg, Augsburg, Bad Reichenhall, Baden-Baden, Balingen
2023-09-12
Recruiting
Hoffmann-La Roche
Phase 3
230
Amberg, Berlin, Bottrop, Düsseldorf, Erfurt, Erlangen, Freiburg im Breisgau, München
2023-09-08
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Amberg, Berlin, Kiel, Ludwigshafen, Regensburg, Stuttgart, Trier, Ulm
2023-09-05
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
32
Amberg, Bad Saarow, Berlin, Brandenburg an der Havel, Bremen, Darmstadt, Essen, Frankfurt
2023-08-28
Active, closed
Alfasigma S.p.A.
Observational
509
Grünwald, Amberg, Dachau, Hamburg, Heidelberg, Kiel, Leipzig, Münster
2023-06-12
Recruiting
Women's Cancer Study Group GmbH
Observational
1,470
Baden-Baden, Pforzheim, Stuttgart, Ulm, Weinheim, Karlsruhe, Ravensburg, Amberg
2022-12-07
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Munich, München, Hanover, Leipzig, Amberg, Berlin, Chemnitz, Dresden
2022-10-24
Recruiting
Institut fuer Frauengesundheit
Phase 4
1,000
Erlangen, Mainz, Bottrop, Amberg, Aschaffenburg, Augsburg, Bamberg, Berlin
2022-10-12
Recruiting
AGO Study Group
Phase 3
970
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Brandenburg an der Havel, Bremen, Chemnitz
2022-09-13
Recruiting
Prof. Wolfgang Janni
Phase 4
300
Aalen, Amberg, Aschaffenburg, Augsburg, Berlin, Biberach, Bonn, Braunschweig
2022-04-27
Recruiting
Dominik Paul Modest
Phase 3
507
Amberg, Bad Saarow, Bayreuth, Berlin, Bochum, Bonn, Bremen, Chemnitz
2021-12-06
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Amberg, Bayreuth, Berlin, Cologne, Düsseldorf, Erfurt, Frankfurt, Halle
2021-08-25
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Aachen, Amberg, Berlin, Bochum, Cologne, Dresden, Düsseldorf, Erlangen
2021-07-06
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Amberg, Berlin, Bochum, Dresden, Frankfurt am Main, Hamburg, Herne, Mönchengladbach
2021-06-24
Active, closed
AstraZeneca
Observational
752
Böblingen, Göttingen, Nürtingen, Osnabrück, Rotenburg (Wümme), Aachen, Amberg, Aschaffenburg
2021-06-15
Active, closed
Alfasigma S.p.A.
Observational
1,304
Altenburg, Amberg, Bad Doberan, Berlin, Demmin, Dresden, Düsseldorf, Ehringshausen
2021-05-11
Active, closed
Incyte Corporation
Phase 3
654
Amberg, Berlin, Essen, Giessen, Greifswald, Landshut, Mainz, Mannheim
2021-04-15
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Aachen, Amberg, Aue, Bad Elster, Bad Friedrichshall, Bad Homburg, Bad Krozingen, Bad Segeberg
2021-01-15
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Immenstadt im Allgäu, Amberg, Augsburg, Bad Homburg, Berlin, Braunschweig, Chemnitz, Cologne
2020-12-02
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Amberg, Berlin-Spandau, Detmold, Essen
2020-03-01
Active, closed
Tesaro, Inc.
Phase 3
785
Amberg, Bad Homburg, Cologne, Dessau, Dresden, Essen, Frankfurt, Giessen
2019-07-18
Active, closed
Wuerzburg University Hospital
Phase 3
576
Freiburg im Breisgau, Mutlangen, Ravensburg, Stuttgart, Ulm, Villingen-Schwenningen, Amberg, Augsburg
2018-08-28
Active, closed
University Hospital Tuebingen
Phase 3
1,065
Amberg, Augsburg, Bad Kreuznach, Bremen, Dresden, Düsseldorf, Erfurt, Esslingen am Neckar
2018-07-27
Recruiting
Endometrial Cancer Lymphadenectomy Trial
NCT03438474Cancer of Endometrium Stage I, Cancer of Endometrium Stage II
Philipps University Marburg
Not applicable
640
Aalen, Amberg, Ansbach, Augsburg, Bad Homburg, Bamberg, Berlin, Bonn
2018-03-28
Active, closed
Eli Lilly and Company
Phase 3
5,637
Freiburg im Breisgau, Friedrichshafen, Ludwigsburg, Tübingen, Ulm, Amberg, Augsburg, Erlangen
2017-07-12
Active, closed
University Hospital Schleswig-Holstein
Not applicable
2,324
Amberg, Aue, Bad Saarow, Bayreuth, Berlin, Bocholt, Bremen, Buchholz
2015-06-16
Rows per page Showing 1–48 of 48
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/amberg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 48 of those studies with a site in Amberg.

How many clinical trials are recruiting in Amberg?

29 of the 48 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Amberg), 48 studies
PhaseStudiesRecruitingShare
Phase 3231347.9%
Observational12725%
Phase 25310.4%
Phase 4438.3%
Not applicable326.3%
Phase 2/3112.1%

Most active sponsors

Lead sponsors with the most studies (Amberg)
Lead sponsorStudiesRecruiting
AstraZeneca107
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest53
AbbVie22
Alfasigma S.p.A.20
Hoffmann-La Roche22
Mirati Therapeutics Inc.21
Novo Nordisk A/S22
The Lymphoma Academic Research Organisation21
Women's Cancer Study Group GmbH22
AGO Study Group11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.